Moreover, the expression of this specific ST3GAL4 mRNA is increased by TNF treatment in both the human bronchial mucosa and in A549 lung cancer cell line, and is correlated with sLex and 6-sulfo-sLex over-expression on glycoproteins. This evidence concerns the gene ST3GAL4 and lung carcinoma.